Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-006555

CEO and CFO bought 3,600 shares at $9.88 ($35,568)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-04-25 Purchase +3,600 $9.88 $35,568 5,570,602 D
Open-market purchases · 3,600 sh · avg $9.88 · $35,568
Loading xslF345X05/ownership.xml…